Cintas (CTAS) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
8 Jul, 2026Executive summary
Third quarter revenue grew 8.4% year-over-year to $2.61 billion, with organic growth at 7.9%.
Net income increased 16.6% to $463.5 million, and diluted EPS rose 17.7% to $1.13, reflecting a stock split.
Operating income increased 17.1% to $609.9 million, with a margin of 23.4%, aided by a $15 million gain on asset sales.
Nine-month revenue reached $7.67 billion, up 7.7% year-over-year, with net income up 17.9% to $1.36 billion and diluted EPS up 18.6% to $3.31.
Quarterly dividend paid was $158.1 million, up 14.9% from last year.
Financial highlights
Gross margin for Q3 was $1.32 billion (50.6% of revenue), up from $1.19 billion (49.4%) a year ago.
Net income margin for Q3 was 17.8%, up from 16.5% last year.
Free cash flow for the nine months ended Feb 28, 2025 was $1.24 billion, up from $1.08 billion.
Net cash provided by operating activities for nine months: $1.53 billion, up from $1.39 billion year-over-year.
Selling and administrative expenses as a percent of revenue decreased to 27.2% from 27.7% for the quarter.
Outlook and guidance
FY25 revenue guidance updated to $10.28–$10.305 billion, reflecting 7.1–7.4% growth vs. FY24.
Organic revenue growth guidance set at 7.4–7.7%.
Annual diluted EPS guidance raised to $4.36–$4.40, implying 15%–16.1% growth.
Guidance assumes no major acquisitions or economic disruptions; foreign currency expected to negatively impact revenue by 0.4% in H2.
Fourth quarter expected to see a normal seasonal pattern, but with a headwind from one less workday.
Latest events from Cintas
- Record revenue and margin growth in 2026; strong 2027 outlook with continued investment.CTAS
Q4 202615 Jul 2026 - Revenue and net income surged, margins expanded, and guidance was raised for the full year.CTAS
Q2 20259 Jul 2026 - Revenue and profit surged, margins expanded, and guidance was raised amid strong capital returns.CTAS
Q1 20259 Jul 2026 - Q1 revenue and net income rose 8.7%, with raised guidance and strong share repurchases.CTAS
Q1 20269 Jul 2026 - Record growth, margin expansion, and a four-for-one stock split set the stage for 2025.CTAS
Q4 20248 Jul 2026 - Record revenue, margin highs, and raised guidance driven by broad-based growth and strong retention.CTAS
Q2 20268 Jul 2026 - Q3 revenue up 8.9%, record margins, guidance raised, $5.5B UniFirst deal announced.CTAS
Q3 20267 Apr 2026 - $5.5B merger delivers $375M synergies, $310/share for UniFirst, closing in H2 2026.CTAS
M&A announcement11 Mar 2026 - Directors and key proposals were voted on, with all board and management recommendations approved.CTAS
AGM 202418 Jan 2026